跳至主要内容
临床试验/NCT07293429
NCT07293429招募中不适用

Effects of Combined Posture Correction Exercise and Resistive Respiratory Muscle Training on Dyspnea, Chest Expansion, Craniovertebral Angle and Pulmonary Function Test, in COPD Patients With Forward Head Posture

Riphah International University1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2025年12月2日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
72
试验地点
1
主要终点
Dyspnea-12 questionnaire:

研究概览

简要总结

Chronic obstructive pulmonary disease (COPD) is characterized by persistent respiratory symptoms and airflow limitation, often exacerbated by postural abnormalities such as forward head posture (FHP). FHP can lead to significant alterations in breathing patterns, reducing the efficiency of respiratory muscles and impairing lung function. Patients with COPD and FHP frequently exhibit muscular imbalances, where overactive accessory muscles compensate for weakened primary respiratory muscles Resistive Inspiratory Muscle Training strengthens inhalation muscles using resistance devices to enhance respiratory function in COPD patients. Resistive Expiratory Muscle Training focuses on strengthening exhalation muscles through resistance during exhalation, improving breathing efficiency. Posture Correction Exercises address forward head posture by stretching tight muscles and strengthening weak ones to optimize breathing mechanics. Combined Resistive Inspiratory and Expiratory Muscle Training integrates both inspiratory and expiratory muscle training, using resistance for both inhalation and exhalation, to maximize respiratory efficiency and overall lung function in COPD patients. The objective of the study is to determine the effects of combined exercise and resistive respiratory muscles training on dyspnea, chest expansion, craniovertebral angle and pulmonary function test, in COPD patients with forward head posture.

Patients of COPD with forward head posture will be recruited by convenient sampling technique using seal opaque method. 72 patients will be equally divided into three groups with 24 patients each. Posture correction exercises will be added as baseline treatment for all three groups session. GROUP A will be treated with resistive inspiratory muscles training (RIMT). GROUP B will be treated with resistive expiratory muscles training (REMT). GROUP C will be treated with combined resistive inspiratory and expiratory muscles technique (RIMT+REMT).treatment session will be of 8 weeks and will include three reading (pre, post treatment and one follow-up). Outcomes measurement will include; dyspnea by dyspnea 12 questionnaires, chest expansion by measuring tape, craniovertebral angle by radiograph and pulmonary function test by spirometer. Data will be analyzed by SPSS software version 21.

详细描述

Chronic Obstructive Pulmonary Disease (COPD) is a widespread, curable, and preventable disease marked by chronic respiratory airway and/or alveolar abnormalities that result in discomfort and airflow limitation; they are usually brought on by prolonged exposure to harmful particles or gases. Even without airflow blockage, there may be serious lung disease (emphysema), making it necessary for a thorough examination. The 4.5 million deaths per year from COPD and related illnesses that are anticipated to occur by 2030 have been extended to approximately 5.4 million deaths per year by 2060.(1) The definition of Chronic Obstructive Pulmonary Disease (COPD) has evolved to encompass a broader understanding beyond just emphysema and chronic bronchitis. Emphysema specifically refers to the destruction of the alveoli, while chronic bronchitis is characterized by a persistent cough and sputum production. However, neither of these terms fully addresses the significant impact of airflow limitation on the morbidity and mortality of COPD patients. It's important to recognize that chronic cough and sputum may occur before airflow limitation develops, and some individuals can experience airflow limitation without these symptoms. This complexity illustrates that COPD includes various structural changes and clinical manifestations, making it inadequate to focus solely on emphysema or chronic bronchitis. A more comprehensive view aids in better diagnosing and managing COPD, ensuring that patients receive care tailored to their unique situations.(2) Symptoms of Chronic Obstructive Pulmonary Disease (COPD) are often perceived as stable in a progressive condition, but recent evidence highlights significant variability in their expression. Breathlessness is the hallmark symptom, yet the overall symptom burden-including cough, sputum production, wheezing, and chest tightness-has a profound negative impact on health status, quality of life, and daily activities. This burden is also associated with increased levels of anxiety and depression, a heightened risk of exacerbations, and worse disease outcomes.

Patients frequently report that morning symptoms, particularly cough and sputum production, are the most severe, correlating with reduced daily functioning and an increased risk of exacerbations. Additionally, nighttime symptoms and sleep disturbances are prevalent but often overlooked in COPD management. These nighttime issues can adversely affect lung function, exacerbate the frequency of episodes, and compromise cardiovascular health, cognition, and overall quality of life.

Moreover, there is considerable variability in symptoms, with many patients experiencing fluctuations on daily, weekly, and seasonal bases. A significant number of individuals report worsening symptoms during the winter months, likely due to environmental factors and increased exposure to respiratory infections. This variability emphasizes the need for personalized management strategies to effectively address the diverse experiences of those living with COPD.(3) Risk factors for Chronic Obstructive Pulmonary Disease (COPD) include a variety of influences that can act independently or interact synergistically. The most critical of these is cigarette smoking, which is the leading cause of chronic bronchitis and emphysema. Other significant contributors include exposure to air pollution and specific occupational hazards. Epidemiological studies have established a strong link between the prevalence of chronic bronchitis and low socioeconomic status. Additionally, endogenous risk factors such as gender, genetic predispositions, childhood respiratory issues, and family history must also be considered in the etiology of COPD.(4) The primary characteristic of Chronic Obstructive Pulmonary Disease (COPD) is persistent expiratory airflow limitation, which leads to air trapping and subsequent hyperinflation. This hyperinflation often develops early in the disease progression and is a key mechanism contributing to exertional dyspnea. Research has indicated that secondary postural changes in the chest wall, along with impaired chest mobility, may arise in response to lung hyperinflation and increased respiratory effort, further compromising the mechanical efficiency of the rib cage's inspiratory muscles.

The treatment algorithm focuses on the ABCD assessment to determine the initial treatment approach. Follow-up management involves adjusting the treatment cycle based on changes in dyspnea or exacerbations, consistent with the 2019 guidelines. The approach to managing persistent dyspnea with add-on bronchodilators and recurrent exacerbations with inhaled corticosteroids aligns with the GOLD 2019 recommendations. The role of inhaled corticosteroids (ICS) has been further clarified in the GOLD 2020 guidelines. Additionally, non-pharmacological treatments, including interventional procedures like endobronchial valves, are recommended based on appropriate indications.(1) Consequently, enhancing postural alignment and the mobility of the chest wall, spine, and shoulders has become a recommended component of comprehensive pulmonary rehabilitation programs. However, the potential effects of such interventions in COPD patients, particularly those with forward head posture, remain uncertain. There is a significant gap in understanding how pulmonary dysfunction interacts with posture and the mobility of the upper body, including the head, cervical and thoracic spines, thorax, and upper limbs.(5) Forward head posture (FHP) is characterized by an anterior deviation of the head in the sagittal plane. This posture is commonly seen in individuals who spend extended periods working at computers or those with chronic conditions. Despite its simplicity, FHP can have significant biomechanical effects on the body. Notably, any changes to the respiratory system can lead to further systemic complications.

Forward head posture (FHP) significantly alters breathing patterns. Ideally, during normal respiration, the chest should expand horizontally, beginning with abdominal breathing rather than chest breathing. In individuals with FHP, overactive sternocleidomastoid (SCM), trapezius, and scalene muscles improperly elevate the clavicles, leading to a dysfunctional upper chest breathing pattern and contributing to muscular imbalances. Research indicates that FHP patients with chronic neck pain exhibit shorter and weaker respiratory muscles compared to healthy individuals. Increased FHP compromises the diaphragm's ability to expand effectively, resulting in reliance on accessory muscles, elevating the ribcage, reducing thoracoabdominal mobility, and impairing diaphragmatic ventilation. As these respiratory muscles become more engaged, alveolar ventilation decreases, and the greater effort required from accessory muscles can lead to fatigue. Muscle imbalance plays a significant role in FHP, which further diminishes lung function, reducing forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), peak expiratory flow rate (PEFR), and maximal inspiratory and expiratory pressures. Additionally, early FHP can affect muscular strength and stiffness.(6) This review seeks to examine the impact of FHP on breathing function, providing valuable insights for physical medicine and rehabilitation specialists. Understanding how FHP interacts with respiratory health is essential for developing effective management strategies for chronic respiratory disorders, including Chronic Obstructive Pulmonary Disease (COPD). By addressing the connection between posture and respiratory function, we can improve rehabilitation outcomes for patients affected by these conditions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
40 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • • Patients of COPD at stage 1 and 2
  • COPD with forward head posture.
  • Craniovertebral angle < 53 degrees (20)
  • Age 40-60
  • Both genders
  • Spirometric evidence of significant chronic air-flow limitation (ie, FEV1 of 50% of predicted and FEV1/FVC ratio of 70% of predicted) in whom COPD had been diagnosed (21)
  • Persistent dyspnea with a self-rated intensity of ⩾6 (out of 10) on a visual analogue
  • Having muscular tightness (pectoralis major and minor, upper trapezius, sternocleidomastoid)

排除标准

  • • COPD with severe complications (respiratory infections, acute exacerbations, pulmonary hypertension)
  • COPD with cardiovascular complications (Cor Pulmonale, atherosclerosis, risk of venous thromboembolism)
  • Unstable respiratory, neurological, and cardiovascular conditions
  • Congenital Cervical/spinal deformity
  • Patients with frozen shoulder, shoulder, cervical radiculopathy)
  • Uncontrolled underlying conditions(22)

结局指标

主要结局

Dyspnea-12 questionnaire:

时间窗: pretreatment, 4th week, 8th week

The Dyspnoea-12 (D-12), particularly evaluates both the physical and emotional components of dyspnea, was created to provide a quick, reliable assessment that is applicable to a wide range of cardiorespiratory conditions. Twelve items on the D-12 measure dyspnea on a four-point scale from none to mild, moderate, and severe. The physical domain is the sum of the scores for the first seven items, which range from 0 to 21. The affective domain scores, which range from 0 to 15, are the sum of the remaining five items. The D-12 total scores, which range from 0 to 36, are the sum of the twelve items. Severity can be determined by higher scores. The test provided significant evidence of assessing characteristics such as construct validity, internal consistency, and structural validity in the Norwegian-language D-12

Measuring tape

时间窗: pretreatment, 4th week, 8th week

The tape measure is a conventional instrument used to assess chest expansion. It measures circumferentially at predetermined spots on the chest wall. Assuring that the underlying soft tissues have not been compressed will assist in helping the tape conform to the chest wall. (24) A tape is used at two distinct rib cage positions to quantify chest expansion. Three anatomical landmarks for thoracic expansion will be the angle of Louis on sternum, xiphoid process of mid chest expansion, midpoint between the xiphoid process and umbilicus for lower chest expansion. Measurements of chest expansion performed with a tape on the upper and lower thoracic levels have a strong relationship and exhibit good intra- and inter-rater reliability and consistency.

Radiograph

时间窗: pretreatment, 4th week, 8th week

One of the common objective methods for evaluating head posture is the measurement of craniovertebral (CV) angle. It is the angle formed when a line drawn horizontally through the seventh cervical (C7) vertebra's spinous process and a line connecting it to the tragus of ear. Radiographic measurements play a crucial role in assessing cervical spine alignment in the sagittal plane by evaluating the relative positions of the vertebrae and joints

Spirometer

时间窗: pretreatment, 4th week, 8th week

A spirometer is a device that measures the amount of air that a person can inhale and exhale during a predetermined period of time. This measurement is typically performed to diagnose lung diseases, specifically blockage and reorganization, forced vital capacity (FVC), and forced expiratory volume in one second (FEV1) are a few spirometer characteristics that are utilized for clinical assessment. The existence or lack of anomalies in the lung can be detected using two of the three measures. Spirometry is an easy, safe, non-invasive, and reasonably priced diagnostic tool for identifying airflow blockage. Spirometry, one of the currently available methods for the early detection of asthma and COPD, is therefore very crucial. It is advised that patients with asthma and COPD measure their static and dynamic respiratory functions every day in order to easily monitor their lung health and avoid exacerbations.

次要结局

  • COPD assessment test (CAT)(pretreatment, 4th week, 8th week)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验